Figure 1
Figure 1. Representative dot-plots of intracellular cytokine expression as evaluated by flow cytometry. Samples from the same patient, in this case a responder, were analyzed before rituximab therapy and 3 months after the first rituximab infusion. The sample of a control subject has been reported for comparison. In the upper plots, CD4+ cells were sorted into Th1 and Th2 subsets according to the expression of either IFN-γ or IL-4. In the lower plots, CD8+ cells were sorted into Tc1 and Tc2 subsets according to the expression of either IFN-γ or IL-4. At 3 months, the patient sample showed an increase of the percentage of Th2 and Tc2 cells compared with baseline, with values very similar to the control sample.

Representative dot-plots of intracellular cytokine expression as evaluated by flow cytometry. Samples from the same patient, in this case a responder, were analyzed before rituximab therapy and 3 months after the first rituximab infusion. The sample of a control subject has been reported for comparison. In the upper plots, CD4+ cells were sorted into Th1 and Th2 subsets according to the expression of either IFN-γ or IL-4. In the lower plots, CD8+ cells were sorted into Tc1 and Tc2 subsets according to the expression of either IFN-γ or IL-4. At 3 months, the patient sample showed an increase of the percentage of Th2 and Tc2 cells compared with baseline, with values very similar to the control sample.

Close Modal

or Create an Account

Close Modal
Close Modal